| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
From the Department of Medicine (M.B.), Internal Medicine I, Medical Policlinic, University Hospital Zürich, Zurich, Switzerland; Molecular Physiology Laboratory (J.J.M., M.A.B.), Centre for Cardiovascular Science, Queens Medical Research Institute, University of Edinburgh, Edinburgh, United Kingdom; and the Division of Nephrology (M.K.), Department of Internal Medicine, University of Michigan, Ann Arbor. * To whom correspondence should be addressed. E-mail: barton{at}usz.ch.
Related Article:
Role of Endothelin Receptors for Renal Protection and Survival in Hypertension. Waiting for Clinical Trials
Matthias Barton*;
Hypertension 2006 48: 965-971.
This article has been cited by other articles:
![]() |
M. Barton and M. R. Meyer Postmenopausal Hypertension: Mechanisms and Therapy Hypertension, July 1, 2009; 54(1): 11 - 18. [Full Text] [PDF] |
||||
|
Hypertension Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 2006 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |